|
Report Date : |
20.04.2013 |
IDENTIFICATION DETAILS
|
Name : |
CHANGZHOU
JOYOUS CHEMICAL CO., LTD. |
|
|
|
|
Registered Office : |
Room 1201
Building 2, Fuchen Commercial Plaza, Xinbei District Changzhou, Jiangsu Province
213022 Pr |
|
|
|
|
Country : |
China |
|
|
|
|
Financials (as on) : |
31.07.2012 |
|
|
|
|
Date of Incorporation : |
26.11.2008 |
|
|
|
|
Com. Reg. No.: |
320407000109050 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Subject is engaged in international trade zainly include Aripiprazole,
Capecitabine, Entacapone, Entacavir, Erlotinib hydrochloride, Etofibrate,
Febuxostat, Fludarabine Phosphate, Gabapentin, Gemcitabine HCl, Ibandronate
sodium, etc. |
|
|
|
|
No. of Employees : |
5 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Small Company |
|
|
|
|
Payment Behaviour : |
Slow but Correct |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
china - ECONOMIC OVERVIEW
Since the late 1970s China has moved from a closed, centrally planned system to a more market-oriented one that plays a major global role - in 2010 China became the world's largest exporter. Reforms began with the phasing out of collectivized agriculture, and expanded to include the gradual liberalization of prices, fiscal decentralization, increased autonomy for state enterprises, creation of a diversified banking system, development of stock markets, rapid growth of the private sector, and opening to foreign trade and investment. China has implemented reforms in a gradualist fashion. In recent years, China has renewed its support for state-owned enterprises in sectors it considers important to "economic security," explicitly looking to foster globally competitive national champions. After keeping its currency tightly linked to the US dollar for years, in July 2005 China revalued its currency by 2.1% against the US dollar and moved to an exchange rate system that references a basket of currencies. From mid 2005 to late 2008 cumulative appreciation of the renminbi against the US dollar was more than 20%, but the exchange rate remained virtually pegged to the dollar from the onset of the global financial crisis until June 2010, when Beijing allowed resumption of a gradual appreciation. The restructuring of the economy and resulting efficiency gains have contributed to a more than tenfold increase in GDP since 1978. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, China in 2010 stood as the second-largest economy in the world after the US, having surpassed Japan in 2001. The dollar values of China's agricultural and industrial output each exceed those of the US; China is second to the US in the value of services it produces. Still, per capita income is below the world average. The Chinese government faces numerous economic challenges, including: (a) reducing its high domestic savings rate and correspondingly low domestic demand; (b) sustaining adequate job growth for tens of millions of migrants and new entrants to the work force; (c) reducing corruption and other economic crimes; and (d) containing environmental damage and social strife related to the economy's rapid transformation. Economic development has progressed further in coastal provinces than in the interior, and by 2011 more than 250 million migrant workers and their dependents had relocated to urban areas to find work. One consequence of population control policy is that China is now one of the most rapidly aging countries in the world. Deterioration in the environment - notably air pollution, soil erosion, and the steady fall of the water table, especially in the North - is another long-term problem. China continues to lose arable land because of erosion and economic development. The Chinese government is seeking to add energy production capacity from sources other than coal and oil, focusing on nuclear and alternative energy development. In 2010-11, China faced high inflation resulting largely from its credit-fueled stimulus program. Some tightening measures appear to have controlled inflation, but GDP growth consequently slowed to near 9% for 2011. An economic slowdown in Europe is expected to further drag Chinese growth in 2012. Debt overhang from the stimulus program, particularly among local governments, and a property price bubble challenge policy makers currently. The government's 12th Five-Year Plan, adopted in March 2011, emphasizes continued economic reforms and the need to increase domestic consumption in order to make the economy less dependent on exports in the future. However, China has made only marginal progress toward these rebalancing goals.
|
Source : CIA |
CHANGZHOU
JOYOUS CHEMICAL CO., LTD.
ROOM 1201
BUILDING 2, FUCHEN COMMERCIAL PLAZA, XINBEI DISTRICT CHANGZHOU, JIANGSU PROVINCE
213022 PR CHINA
TEL: 86 (0)
519-85607258
FAX: 86 (0)
519-85607278
Date of Registration : NOVember 26, 2008
REGISTRATION NO. : 320407000109050
LEGAL FORM : Limited Liability Company
CHIEF EXECUTIVE :
LU XIAOQIANG (LEGAL REPRESENTATIVE)
REGISTERED CAPITAL : CNY 1,000,000
staff :
5
BUSINESS CATEGORY : TRADING
REVENUE :
CNY 7,654,000 (JAN. 1 2012 TO
JUL. 31, 2012)
EQUITIES :
CNY 1,356,000 (AS OF JUL. 31, 2012)
WEBSITE : www.joyouschem.com
E-MAIL :
sales@joyouschem.com
PAYMENT :
AVERAGE
MARKET CONDITION : average
FINANCIAL CONDITION : fairly stable
OPERATIONAL TREND : ordinary
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE :
CNY 6.18 = USD 1
Adopted
abbreviations (as follows)
SC - Subject Company
(the company inquired by you)
N/A – Not available
CNY – China Yuan Ren
Min Bi
This section aims at indicating the relative positions of SC in respect
of its operational trend & general reputation
Operational Trend:- General
Reputation:-
Upward Excellent
Steady Good
Fairly Steady Fairly
Good
Ordinary Average
Fair Fair
Stagnant Detrimental
Downward Not
known
Not known Not
yet be determined
Not yet be determined
SC was established as a limited liabilities company of PRC with State
Administration of Industry & Commerce (SAIC) under registration No.: 320407000109050 on November 26, 2008.
SC’s Organization Code Certificate No.:
68297007-0

SC’s Tax No.: 320400682970070
SC’s registered capital: CNY 1,000,000
SC’s paid-in capital: CNY 1,000,000
Registration Change Record:-
No significant changes of SC have been noted
in SAIC since its incorporation.
Current Co search indicates SC’s shareholders & chief executives are
as follows:-
|
Name of Shareholder (s) |
% of Shareholding |
|
Lu Xiaoqiang |
80 |
|
Yang Tong |
20 |
SC’s Chief Executives:-
|
Position |
Name |
|
Legal Representative, Chairman, and General Manager |
Lu Xiaoqiang |
|
Supervisor |
Yang Tong |
No recent development was found during our checks at present.
Name %
of Shareholding
Lu Xiaoqiang 80
Yang Tong 20
Lu Xiaoqiang, Legal Representative, Chairman and General
Manager
------------------------------------------------------------------------------------------------------
Gender: M
Age: 38
ID# 321119197512194914
Qualification: University
Working experience (s):
From 2008 to present, working in SC as legal representative, chairman
and general manager
Yang Tong,
Supervisor
---------------------------------------
Gender: F
Age: 36
ID# 450205197712120026
SC’s registered business scope includes wholesaling hazardous chemicals;
selling chemical materials and products; information consulting service;
importing and exporting various goods and technology.
SC is mainly engaged in international trade.
SC’s products mainly include: Aripiprazole, Capecitabine, Entacapone,
Entacavir, Erlotinib hydrochloride, Etofibrate, Febuxostat, Fludarabine
Phosphate, Gabapentin, Gemcitabine HCl, Ibandronate sodium, etc.
SC sources its materials 100% from domestic market. SC sells 100% of its products to the overseas market, mainly India.
The buying terms of SC include Check, T/T and Credit of 30-60 days. The
payment terms of SC include T/T, L/C and Credit of 30-60 days.
*Major Supplier:
============
Suzhou Zhensu Fine Chemical Co., Ltd.
Staff &
Office:
--------------------------
SC is known to have approx. 5
staff at present.
SC rents an area as its operating office of approx. 100 sq. meters at
the heading address.
SC is not known to have any subsidiary at present.
Overall payment appraisal:
( ) Excellent ( ) Good
(X) Average ( ) Fair ( ) Poor ( ) Not yet be determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment experience (through current enquiry with SC's
suppliers), our delinquent payment and our debt collection record concerning
SC.
Trade payment experience: SC’s suppliers declined to make any
comments.
Delinquent payment record: None in our database.
Debt collection record: No overdue amount
owed by SC was placed to us for collection within the last 6 years.
Basic Bank:
Bank of China Xinbei Sub-branch
AC#: 403090830149533508091001
Balance Sheet
|
Unit: CNY’000 |
As
of Jul. 31, 2012 |
|
2,511 |
|
|
Notes receivable |
0 |
|
Accounts receivable |
357 |
|
Advances to suppliers |
0 |
|
Other receivable |
472 |
|
Inventory |
3,597 |
|
Non-current assets within one year |
0 |
|
Other current assets |
381 |
|
|
------------------ |
|
Current assets |
7,318 |
|
Fixed assets |
140 |
|
Long-term prepaid expenses |
0 |
|
Deferred income tax assets |
0 |
|
Other non-current assets |
3 |
|
|
------------------ |
|
Total assets |
7,461 |
|
|
============= |
|
Short-term loans |
0 |
|
Notes payable |
0 |
|
Accounts payable |
5,715 |
|
Advances from clients |
241 |
|
Other payable |
0 |
|
Other current liabilities |
149 |
|
|
------------------ |
|
Current liabilities |
6,105 |
|
Non-current liabilities |
0 |
|
|
------------------ |
|
Total liabilities |
6,105 |
|
Equities |
1,356 |
|
|
------------------ |
|
Total liabilities & equities |
7,461 |
|
|
============= |
Income Statement
|
Unit: CNY’000 |
Jan.
1 2012 to Jul. 31, 2012 |
|
Revenue |
7,654 |
|
Cost of sales |
7,118 |
|
Sales expense |
52 |
|
Management expense |
342 |
|
Finance expense |
25 |
|
Profit before tax |
116 |
|
Less: profit tax |
17 |
|
99 |
Important Ratios
=============
|
|
As
of Jul. 31, 2012 |
|
*Current ratio |
1.20 |
|
*Quick ratio |
0.61 |
|
*Liabilities to assets |
0.82 |
|
*Net profit margin (%) |
1.29 |
|
*Return on total assets (%) |
1.33 |
|
*Inventory / Revenue ×210 |
99 days |
|
*Accounts receivable/ Revenue ×210 |
10 days |
|
* Revenue/Total assets |
1.03 |
|
* Cost of sales / Revenue |
0.93 |
PROFITABILITY:
AVERAGE
The revenue of SC appears average in its line.
SC’s net profit margin is average.
SC’s return on total assets is average.
SC’s cost of sales is fairly high, comparing with its revenue.
LIQUIDITY: FAIR
The current ratio of SC is maintained in a normal level.
SC’s quick ratio is maintained in a fair level.
The inventory of SC appears large.
The accounts receivable of SC is maintained in an average level.
SC has no short-term loans.
SC’s revenue is in an average level, comparing with the size of its
total assets.
LEVERAGE: FAIR
The debt ratio of SC is fairly high.
The risk for SC to go bankrupt is above average.
Overall financial
condition of the SC: Fairly Stable.
SC is considered small-sized in its line with fairly stable financial
conditions. The large amount of inventory may be a threat to SC’s financial
condition.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.03 |
|
|
1 |
Rs.82.43 |
|
Euro |
1 |
Rs.70.49 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.